Plasticity and Power: How MEIS Transcription Factors Define Melanoma Aggressiveness
Gene Editing · 2026 · 1 (1) · 1-28
DOI: 10.29228/genediting.94090 ↗Kurz gefasst
Fachartikel in der Zeitschrift Gene Editing, 2026. Verfasst von Asya Kurtuluş.
Abstract (Originalsprache)
Melanoma is a highly aggressive malignancy characterized by significant phenotypic plasticity and the co-option of embryonic gene expression programs. Among the critical regulators of this process are the TALE-class homeobox transcription factors MEIS1, MEIS2, and MEIS3. These transcriptional assemblies act as central nodes that integrate hallmark oncogenic signaling pathways, such as the MAPK, PI3K/AKT, and TGF-beta axes, to drive tumor cell survival, proliferation, and invasiveness. The review further explores how MEIS factors influence the epigenetic landscape and phenotypic switching between differentiated and stem-like, dedifferentiated states. By orchestrating these developmental programs, MEIS1-3 proteins fundamentally reinforce the malignant identity of melanoma cells throughout the various stages of cancer progression.
Zitieren
APA
Kurtuluş, A. (2026). Plasticity and Power: How MEIS Transcription Factors Define Melanoma Aggressiveness. Gene Editing, 1(1), 1-28. https://doi.org/10.29228/genediting.94090
Vancouver
Kurtuluş A. Plasticity and Power: How MEIS Transcription Factors Define Melanoma Aggressiveness. Gene Editing. 2026;1(1):1-28. doi:10.29228/genediting.94090
BibTeX
@article{Kurtulu2026,
author = {Kurtuluş, Asya},
title = {Plasticity and Power: How MEIS Transcription Factors Define Melanoma Aggressiveness},
journal = {Gene Editing},
year = {2026},
volume = {1},
number = {1},
pages = {1--28},
doi = {10.29228/genediting.94090}
}
EUVIMED